Identification of key genes and signaling pathway in the pathogenesis of Huntington's disease via bioinformatics and next generation sequencing data analysis
Basavaraj Mallikarjunayya VastradiD, Chanabasayya Mallikarjunayya VastradiD
Abstract
Huntingtons disease (HD) is the primary cause of progressive motor deficits, psychiatric symptoms, and cognitive impairment. The exact molecular mechanisms of HD pathogenesis are largely unknown. This investigation aims to identify the hub genes, miRNA and TFs in HD and explore their potential molecular regulatory network. Next generation sequencing (NGS) dataset (GSE105041) was extracted from the Gene Expression Omnibus (GEO) database. An integrated bioinformatics pipeline including identification of differentially expressed genes (DEGs), Gene ontology and REACTOME pathway enrichment analysis, protein-protein interaction (PPI) network and module analysis, miRNA-hub gene regulatory network analysis and TF-hub gene regulatory network analysis, and receiver operating characteristic curve (ROC) analysis were applied to identify hub genes, miRNA and TFs, and key drivers of HD pathogenesis. We identified 958 DEGs in the discovery phase, consisting of 479 up regulated genes and 479 down regulated genes. GO and REACTOME enrichment analyses of the 479 up regulated genes and 479 down regulated genes showed that they were mainly involved in multicellular organismal process, developmental process, signaling by GPCR and MHC class II antigen presentation. Further analysis of the PPI network using Cytoscape and PEWCC plugins identified 10 hub genes, including LRRK2, MTUS2, HOXA1, IL7R, ERBB3, EGFR, TEX101, WDR76, NEDD4L and COMT. Possible target miRNAs and TFs, including hsa-mir-1292-5p, hsa-mir-4521, ESRRB and SREBF1, were predicted by constructing a miRNA-hub gene regulatory network analysis and TF-hub gene regulatory network. This investigation used bioinformatics methods to explore the molecular pathogenesis of HD, and identified potential molecular markers. These molecular markers might provide novel ideas and methods for the early diagnosis, treatment, and monitoring of HD.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- FWCI
- 0.79
- Field percentile
- top 35%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Identification of Blood Based biomarker for Huntington's disease using in-silico gene expression analysis
Souvik Chakraborty·bioRxiv·Mar 26, 2021
- Bioinformatics and next generation sequencing data analysis to identify key genes and pathways influencing in Parkinson's disease
Basavaraj Mallikarjunayya Vastrad, Chanabasayya Mallikarjunayya Vastrad·Genome Instability & DiseasePeer-reviewed·May 16, 2025
- Identification of Key Pathways and Genes in Dementia via Integrated Bioinformatics Analysis
Basavaraj Mallikarjunayya Vastrad, Chanabasayya Mallikarjunayya Vastrad·bioRxiv·Apr 18, 2021
- Identification of candidate biomarkers and signaling pathways associated with Alzheimer's disease using bioinformatics analysis of next generation sequencing data
Basavaraj Mallikarjunayya Vastrad, Chanabasayya Mallikarjunayya Vastrad·bioRxiv·Dec 3, 2024
- Huntingtin loss-of-function contributes to transcriptional deregulation in Huntington's disease
Emilia Kozłowska, Agata Ciołak, … Agnieszka Fiszer·Cell & BiosciencePeer-reviewed·Jul 9, 2025
- Identification of candidate biomarkers and pathways associated with multiple sclerosis using bioinformatics and next generation sequencing data analysis
Basavaraj Mallikarjunayya Vastrad, Shivaling Pattanashetti, Chanabasayya Mallikarjunayya Vastrad·bioRxiv·Dec 5, 2023